🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06852378
Recruiting Observational

Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

NCT06852378 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-03-01
Last updated
2025-03-04

Condition(s) studied

Iliopsoas Nerve BlockFemoral Nerve BlockHip Fracture Surgeries

Investigational drug(s) / intervention(s)

Iliopsoas nerve block →Femoral nerve block →

Iliopsoas nerve block: Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Femoral nerve block: Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Study summary

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I and II. * Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty. Exclusion Criteria: * Refusal to participate. * Coagulopathy. * Patients with a history of drug allergies to study drugs. * Inability to cooperate.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ain Shams University Cairo Egypt Recruiting

More Ain Shams University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06852378 on ClinicalTrials.gov ↗ ← All trials in Egypt